Michael Wilmink - Net Worth and Insider Trading
Michael Wilmink Net Worth
The estimated net worth of Michael Wilmink is at least $876,974 dollars as of 2024-09-20. Michael Wilmink is the Director of Eupraxia Pharmaceuticals Inc and owns about 224,865 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) stock worth over $876,974. Details can be seen in Michael Wilmink's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Wilmink has not made any transactions after 2024-09-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Wilmink
Michael Wilmink Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Wilmink owns 1 companies in total, including Eupraxia Pharmaceuticals Inc (TSX:EPRX) .
Click here to see the complete history of Michael Wilmink’s form 4 insider trades.
Insider Ownership Summary of Michael Wilmink
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:EPRX | Eupraxia Pharmaceuticals Inc | 2024-09-10 | Director |
Michael Wilmink Latest Holdings Summary
Michael Wilmink currently owns a total of 1 stock. Michael Wilmink owns 224,865 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) as of September 10, 2024, with a value of $876,974.
Latest Holdings of Michael Wilmink
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:EPRX | Eupraxia Pharmaceuticals Inc | 2024-09-10 | 224,865 | 3.90 | 876,974 |
Holding Weightings of Michael Wilmink
Michael Wilmink Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Wilmink has made a total of 7 transactions in Eupraxia Pharmaceuticals Inc (TSX:EPRX) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Eupraxia Pharmaceuticals Inc is the acquisition of 400 shares on September 10, 2024, which cost Michael Wilmink around $1,426.
Insider Trading History of Michael Wilmink
- 1
Michael Wilmink Trading Performance
GuruFocus tracks the stock performance after each of Michael Wilmink's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Wilmink is -14.91%. GuruFocus also compares Michael Wilmink's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Wilmink within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Wilmink's insider trading performs compared to the benchmark.
Performance of Michael Wilmink
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.05 | | | | | |
| Relative Return to S&P 500(%) | -5.3 | | | | | |
Michael Wilmink Ownership Network
Michael Wilmink Owned Company Details
What does Eupraxia Pharmaceuticals Inc do?
Who are the key executives at Eupraxia Pharmaceuticals Inc?
Michael Wilmink is the Director of Eupraxia Pharmaceuticals Inc. Other key executives at Eupraxia Pharmaceuticals Inc include Senior Officer Amanda Michelle Malone , Senior Officer Paul Anthony Brennan , and Director or Senior Officer of 10% Security Holder James Besser .
Eupraxia Pharmaceuticals Inc (TSX:EPRX) Insider Trades Summary
Over the past 18 months, Michael Wilmink made 4 insider transaction in Eupraxia Pharmaceuticals Inc (TSX:EPRX) with a net purchase of 3,800. Other recent insider transactions involving Eupraxia Pharmaceuticals Inc (TSX:EPRX) include a net purchase of 5,000 shares made by Amanda Michelle Malone , a net purchase of 6,100 shares made by James Allen Helliwell , and a net purchase of 10,000 shares made by Paul Anthony Brennan .
In summary, during the past 3 months, insiders sold 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) in total and bought 1,900 shares, with a net purchase of 1,900 shares. During the past 18 months, 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) were sold and 24,900 shares were bought by its insiders, resulting in a net purchase of 24,900 shares.
Eupraxia Pharmaceuticals Inc (TSX:EPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eupraxia Pharmaceuticals Inc Insider Transactions
Michael Wilmink Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Wilmink. Currently GuruFocus does not have mailing address information for Michael Wilmink.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
